Simon Daniel van Haren

11PUBLICATIONS
71CO-AUTHORS
Biologically active moleculesMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)GlycoconjugatesInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 03, 2025
Discovery of a small molecule TLR3 agonist adjuvant.

Branden Lee, Danica Dong, Etsuro Nanishi

|Jul 03, 2024
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation.

Dheeraj Soni, Francesco Borriello, David A Scott

|Dec 22, 2023
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells.

Julie Zimmermann, Simon D van Haren, Joann Diray-Arce

|Mar 30, 2023
Molecular Determinants of the Early Life Immune Response to COVID-19 Infection and Immunization.

Elisabeth M S Beijnen, Oludare A Odumade, Simon D van Haren

Pageof 2